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Determining themechanism of action of antimicrobial peptides (AMPs) is critical if they are to be developed into
the clinical setting. In recent years high resolution techniques such as atomic force microscopy (AFM) have in-
creasingly been utilised to determine AMP mechanism of action on planar lipid bilayers and live bacteria. Here
we present the biophysical characterisation of a prototypical AMP from the venom of the North African scorpion
Scorpio maurus palmatus termed Smp24. Smp24 is an amphipathic helical peptide containing 24 residues with a
charge of +3 and exhibits both antimicrobial and cytotoxic activity and we aim to elucidate the mechanism of
action of this peptide on both membrane systems.
Using AFM, quartz crystal microbalance-dissipation (QCM-D) and liposomal leakage assays the effect of Smp24
on prototypical synthetic prokaryotic (DOPG:DOPC) and eukaryotic (DOPE:DOPC) membranes has been deter-
mined. Our data points to a toroidal poremechanismagainst the prokaryotic likemembranewhilst the formation
of hexagonal phase non-lamellar phase structures is seen in eukaryotic likemembrane. Also, phase segregation is
observed against the eukaryotic membrane and this study provides direct evidence of the same peptide having
multiple mechanisms of action depending on the membrane lipid composition.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Antimicrobial peptides (AMPs) are essential contributors to the innate
immune system and are found among all biological classes. Over one
thousand AMPs have been discovered and biologically characterised to
date, although themechanism(s) bywhich the vastmajority of these pep-
tides function is not fully understood. Themembrane-disruptive effects of
AMPs arewell establishedwith threemainmechanisms proposed, name-
ly the barrel stave, toroidal pore and carpet models [1]. For each of these
mechanisms the key factor formembrane disruption is the initial electro-
static attraction of the peptide to the negatively charged bacterial mem-
brane surface [2,3]. In all cases, following initial electrostatic attraction, a
threshold concentration must be realized before membrane disruption
can occur [2,4]. In the barrel stave mechanism a central lumen forms
within the pore as a result of peptide oligomerisation [5]. AMPs bind as
amonomer and adopt anα helical secondary structure inducing localised
membrane thinning by sitting at the phospholipid chain/head group in-
terface, upon the threshold concentration being reached the hydrophobic
face inserts into themembrane core and the peptides begin to self associ-
ate [6]. In the toroidalmechanism the pore lumen is lined by both peptide
and lipid head group interactions and is characterised by the induction of
membrane curvature due to interaction of the hydrophilic face of the pep-
tide with polar head groups, this causes bending of the head groups in a
continuous fashion to connect the outer and inner membrane leaﬂet
due to the thermodynamically unfavourable interaction between the
acyl chain and the aqueous environment [7]. In the carpet model [3] the
peptides cover themembrane surface and, upon the threshold concentra-
tion being reached, form transient pores allowing peptide access to the
inner leaﬂet leading to peptide carpet formation on each membrane sur-
face. Peptides can then span the transmembrane bilayer causing curva-
ture of the membrane to protect the acyl chains which leads to the
disintegration of the bilayer due to micelle formation. Recent models
however, have blurred the lines between these three alternatives. While
these mechanisms are still the most frequently proposed, a number of
other mechanisms have emerged including the interfacial, leaky slit, ag-
gregate, electroporation, sinking raft, and lipid aggregate models (see
[2] for an extensive review).
Due to the fundamental role cellular membranes play in the regula-
tion and function of all cells, it is critical for the clinical introduction of
AMPs that we understand the precise mechanisms by which they
interact with both prokaryotic and eukaryotic membranes. Previous
mechanistic studies have focused on the lytic effect of AMPs on lipo-
somes [8,9]; while this has been valuable in determining the propensity
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of a peptide to damage a cell membrane and cause cell death, it does not
inform us of non-lytic effects and membrane structural changes that
could be occurring.
Atomic force microscopy (AFM) has become an established tech-
nique to image planar lipid bilayers [10]; however it has only recently
been employed to determine the mechanism of action of AMPs
[11–15]. A major advantage of AFM over other biophysical techniques
is that it allows nano-scale visualisation of an AMP's effects on a mem-
brane in a pseudo-native state, thereby offering an unparalleled insight
into any membrane changes that may be induced.
Scorpion venoms are a rich source of antimicrobial peptides [16,17].
In this study we have examined the mechanism of action of Smp24 (24
amino acids, charge +3), a prototypical amphipathic AMP that was
identiﬁed by genomic analysis of Scorpiomaurus palmatus [18]. Previous
CD analysis determined Smp24 to be unordered in aqueous solution but
adopts anα-helical structure in the presence of 60% TFEwith twohelical
regions of approximately 59% and 22% predicted [19]. We have used
AFM and quartz crystal microbalance-dissipation (QCM-D) to study
the effects of Smp24 on hydrated lipid membranes, in addition to lipo-
some leakage assays. Our results show that Smp24 has multiple
modes of action, depending on lipid composition. This study highlights
the need for advanced biophysical analysis of the action of AMPs against
a variety of different membrane compositions. At the present moment,
cell lysis is the primary measurable endpoint of AMP action. We expect
our approach will diversify our knowledge and understanding of mem-
brane targets, by increasing the range of outputs by which AMP action
can be evaluated.
2. Materials and methods
2.1. Materials
Smp24 (96.2% pure) was synthesised using solid-phase chemistry
andwas purchased fromThink Peptides (Oxford, UK). Carboxyﬂuoresce-
inwas purchased from Sigma (Gillingham, UK) and all solvents other re-
agents were of the highest grade available and were obtained from
Sigma (Gillingham, UK). Phospholipids 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE-18:1 (Δ9-Cis), 1,2-dioleoyl-sn-glycero-3-
phospho-(1′-rac-glycerol) (DOPG-16:0), 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC-18:1 (Δ9-Cis) and 1′,3′-bis[1,2-dimyristoyl-sn-
glycero-3-phospho]-sn-glycerol (Cardiolipin-14:0) were purchased
from Avanti Polar Lipids (Alabaster, AL).
2.2. AFM imaging of hydrated lipid bilayers
Supported planar lipid bilayers were produced on a freshly cleaved
mica surface by vesicle rupture using tip sonicated vesicles incubated
on the mica at a concentration of 0.5 mg/mL (as described by [20]. For
bilayers containing negatively charged lipids 2 mM CaCl2 was added
to the lipid mixture just before incubation on the surface. After 20 min
incubation the surface was rinsed at least 10 times to remove vesicles
from the bulk phase. The presence of a uniform bilayer was conﬁrmed
by lateral scanning in tappingmodeover a 64 μm2 area and thepresence
of multiple bilayers was ruled out by a statistically signiﬁcant (nine)
number of force spectroscopy curves. Observations of the attack of
Smp24 were performed using a Nanoscope IIIa Multimode atomic
force microscope (Digital instruments Santa Barbara CA).
2.3. QCM-D protocol
QCM-Dmeasurements were performed using a QSense E4 multifre-
quency QCM-D instrument (Q-Sense, Gothenburg, Sweden) in a ﬂow
through cell of 40 μL volume. Data from 15, 25, 35, 45, 55, and 65 MHz
overtones (3rd, 5th, 7th, 9th, 11th, and 13th respectively) were collect-
ed. Before use, all SiO2 crystals were cleaned by ultrasonication in 0.4%
SDS for 15 min followed by copious rinsing and ultrasonication in
water for 15 min. The crystals were then dried under nitrogen and
UV-ozone cleaned for 20 min. After UV-ozone treatment, they were
rinsed with water, dried under nitrogen, and used immediately. Exper-
iments were performed at 22 °C. Lipid vesicles were injected at a con-
centration of 0.5 mg/mL to form the bilayer. After rinsing successive
peptide concentrations (0.2–2.0 μM) were injected at a ﬂow rate of
50 μL/min. Changes in dissipation and normalised frequencyweremon-
itored for a period of 20 mins before the next injection. Changes in the
dissipation (D), and normalised frequency (f, where f = f n/n and n is
the number of the overtone, i.e. n = 3, 5, 7 etc.) of the 5th overtone
(n= 5, 25 MHz) are presented.
2.4. Liposome leakage assay
Liposomes were made using an extruder method with lipids at a
concentration of 0.5 mg/mL [20]. Liposome release assays using carbo-
xyﬂuorescein (CF) were performed as follows: peptide sample (20 μL),
liposomes (10 μL) and buffer (50 mM sodium phosphate, 10 mM NaCl
and 1 mM of ethylenediaminetetraacetic acid (EDTA) pH 7.4) (170 μL)
were incubated in the dark for 15 min. Fluorescence (480/520 nm)
was measured on a Tecan inﬁnite M200 plate reader (Tecan, UK), The
reactionmix without CFwas used as a negative control to normalise re-
sults and 10% Triton-X was used as a positive control to measure com-
plete dye release. The rate of CF leakage was expressed as the
percentage of dye released of the total encapsulated carboxyﬂuorescein
and then normalised against the blank buffer signal. All samples were
run in triplicate.
3. Results
3.1. Analysis of Smp24 using liposome leakage assays
Liposome leakage assays were performed on a number of different
liposome compositions (Fig. 1).
Against a negatively charged PCPG (1:1) (phosphocoline:
phosphoglycerol) composition, signiﬁcant membrane disruption
occurred at an AMP concentration of 1.25 μM with 37.7% (±1.7)
CF release observed and 70.9% (±2.6) leakage seen when the AMP
concentration was increased to 2 μM. The electrostatic nature of
this attack has also been examined with a decrease in CF release in
the presence of 500 mM NaCl, only 6.25% (±1.0) at an AMP concen-
tration of at 1.25 μM and 53.3% (±2.19) at 2 μM AMP was observed.
Against the neutrally charged PCPE (1:1) (phosphocoline:
phosphoethanolamine) composition, CF release is less pronounced
with 19.6% (±1.7) observed at 1.25 μM peptide concentration with
a gradual increase in leakage to 48.7% (±2.0) at 2 μM. However
any membrane disruptive effects are not electrostatically driven
with no signiﬁcant difference in lyses observed in the presence of
salt.
Fig. 1. The effect of Smp24 on a number of different membrane compositions at both 1.25
and 2 μM peptide concentration (Error bars ± SD).
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The inclusion of 10% cardiolipin, common in bacterial membranes,
increased leakage at 1.25 μM Smp24 (PC:PG:CR 45:45:10) when com-
pared with the CR deﬁcient liposomes, with maximum release seen at
1.75 μM and above.
3.2. Analysis of Smp24 attack on hydrated lipid bilayers using AFM
AFM was used to visualize hydrated lipid bilayers following AMP at-
tack with Smp24 (0.4–2.0 μM) against both PC:PG, PC:PE and a bilayer
that exhibits phase separation. Both the PC:PG and PC:PE compositions
were chosen asmodelmembrane compositions to represent prototypical
membranes of prokaryotic and eukaryotic membranes respectively and
sphingomyelin (SM) was incorporated to induce phase separation.
The PC:PG bilayer exhibited a smooth appearance before peptide at-
tack with no visible defects (Fig. 2A), AFM force spectroscopy was used
to conﬁrm the existence of a bilayer as previously shown [20]. Pore for-
mation was seen after treatment with Smp 24 over a concentration
range of 0.4–1.25 μM (Fig. 2B). After 30 min incubation pore size
remained stable over time with diameters ranging between 20 and
150 nm with an average of 80 ± 40 nm (sd) (Fig. 2C). As shown by
Fig. 2D the pore depths were typically 2–4 nm. Increased peptide con-
centration (2.0 μM) caused the complete destruction of the bilayer in
Fig. 2.The effect of Smp24 against negatively charged (1:1) PC:PGmembranes at variouspeptide concentrations. (A): The PC:PG bilayer before Smp24 incubation, (B): Pore formationwith
the PCPG bilayer after incubation with 1.25 μM Smp24, (C): Histogram showing the distribution of detectable pore sizes after incubation with 1.25 μM Smp24 (n= 29), (D): Line proﬁle
across pore in image (B) showing the typical depth of the pores. (E): Complete disruption of a PCPG bilayer after incubationwith 2 μMSmp24with inset showing remaining bilayer patch,
(F) and (G) line proﬁles across areas of image (E) showing the heights of surface vesicles and membrane patches respectively.
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5mins. As can be seen in Fig. 2E, a small number of fragments of bilayer,
~6 nm high, are still on the mica surface (Fig. 2F) whilst the rest of the
surface is either clear or has large 50–200 nm vesicles attached to it
(Fig. 2G).
Following exposure of a PC:PE bilayer to 1.25 μMSmp24 no pore for-
mation is observed; removal of the bilayer in stratiﬁed lines is seen in-
stead (Fig. 3A–C), with the disrupted areas approximately 200 nm
wide, to a depth of 0.3–0.5 nm (Fig. 3D). Addition of higher peptide con-
centrations (2.0 μM) to PC:PE bilayers resulted in increased disruption.
After 5 min incubation the PC:PE bilayer has fewer defects which larger
size compared to the same bilayerwith 1.25 μMSmp24 (Fig. 3A, E). Over
time the shallow defects (0.5 nm) develop further holes which have
depths of 4 nm (Fig. 3G,H). The inclusion of 10% Cholesterol into the
PC:PG lipid mixture showed similar effects of Smp24 attack to that of
the PC:PE membranes. At 1.25 μM Smp24 thinning defects (~0.3 nm
deep) appear within 5 min peptide incubation (Fig. 3I), after 15 min
(Fig. 3J, K) these defects increase in depth to 1 nm (Fig. 3L) with some
areas showing complete membrane removal (~4–5 nm deep defects).
A phase separated bilayer (60% DOPC, 20% Sphingomyelin, 20% Cho-
lesterol) was chosen as a way of investigating the effect of peptide at-
tack on coexisting lipid domains. Before peptide addition, Fig. 4 at 0 s,
lipid ordered (Lo) domains (0.6–0.9 nm high) are observed surrounded
by a lipid disordered (Ld) phase, seen with the lighter coloured areas
being the Lo phase. After exposing bilayers to 1.0 μMpeptide (a concen-
tration to determine the effect onmembraneswithout causing pore for-
mation), the Lo domains reshape and reorganize over time, with some
merging into larger domains whilst others break up into smaller do-
mains. This increase in dynamics combined with the resulting domains
having increased domain perimeter implies a reduction in the domain
interfacial line tension [21]. Analysing the area/perimeter ratio provides
a quantitative measure which can be directly related to the line tension
[22]. Performing this analysis (Fig. 4) on single domains (excluding
domains which merge or break up) clearly shows how the line tension
dramatically decreases over time, reaching a steady state after 25 min.
3.3. Analysis of Smp24 attack on hydrated lipid bilayers using QCM-D
QCM-D curves for PC:PG and PC:PE bilayers after peptide attack with
consecutively increasing concentrations are shown in Fig. 5A & B respec-
tively. In each graph the frequency has been inverted, with a decrease in
frequency representative of an increased peptide accumulation.
At low concentrations of Smp24 (0.1–0.2 μM) acting on PC:PG bilay-
ers, the frequency decreases (−24 Hz to−25.5 Hz) with an increase in
dissipation (0.2 to 0.35). Increasing peptide concentration to 0.75 μM
initially results in large changes in both frequency (to−37.3 Hz) and
dissipation (to 1.6); however, dissipation then falls away to 1.4. This
“swing back” phenomenon could represent a threshold concentration
being overcome and membrane incursion subsequently taking place.
A further injection of 0.75 μMpeptide has little observed effect. Interest-
ingly an increase to 1.25 μM peptide further decreases frequency (to
−45 Hz) and but signiﬁcantly increases dissipation again (to 2.8), pos-
sibly reﬂecting further peptide accumulation and further incursion into
themembrane. In contrast, when PC:PE bilayers are exposed to similar-
ly increasing concentrations of smp24, there is an overall increase in fre-
quency (−27.7 Hz to −24.4 Hz) and a minor decrease in dissipation
(0.66 to 0.44). The lack of dissipation “swing back” would also suggest
that a threshold accumulation and incursion event does not take place
on PC:PE bilayers as no transient stabilisation of the bilayer is seen ex-
pected after initial peptide insertion.
4. Discussion
Prokaryotic membranes are more negatively charged than their eu-
karyotic counterparts, due to an increased presence of the hydroxylated
Fig. 3. AFM images showing the effect of Smp24 on PC:PE (1:1) bilayers (1.25 μM: A–D, and 2.0 μM: E–H) and PC:PG (1:1) + 10% Cholesterol bilayers (1.25 μM: I–L). Images (A, E and
I) show resulting surface topology after 5 min Smp24 incubation whist (B, F and J) show the topology after 15 min. (C, G and K): Zoomed images of the defects created by Smp24 for
the respective bilayer/Smp24 concentrations. (D, H and L): Line proﬁles across defects for the respective bilayer/Smp24 concentrations (dashed lines across the AFM images illustrate
where the proﬁles were taken).
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phospholipids (PG, PS and CR); in comparison eukaryotic membranes
mainly consist of the zwitterionic species (PC, PE, and SM) [22]. Al-
though a number of bacteria do contain PE, for example the outermem-
brane of E. coli is predominantly PE [23,24], the membrane
compositions chosen within this study reﬂect prototypical prokaryotic
and eukaryotic membranes [24,25]. Smp24 exhibits a membrane dis-
ruptive effect on all membrane compositions which is consistent with
its antimicrobial and cytotoxic effects [19].
Amajor driving force of AMP selectivity is the electrostatic attraction
to prokaryotic membranes [25,26] which is demonstrated by the inabil-
ity of Smp24 to disrupt PC:PG liposomes in the presence of 500 mM
NaCl. In contrast, no signiﬁcant salt disruption is seen against the zwit-
terionic bilayer. PE induces negative curvature of the bilayer, resulting
in packing defects [26,27] and a number of peptides (see for example
α-synuclein [27,28] and amphipathic lipid packing sensor (ALPS)motifs
such as synapsin 1 [29,30] and ArfGAP1 [31] interact with membranes
through a process of curvature-sensing. This phenomenon is thought
to be critical to a number of fundamental transport and signalling path-
ways allowing peptides to identify the correct sub-cellular membrane
[31,32]. Upon interaction with the PE containing bilayer Smp24 causes
signiﬁcant rearrangement of the bilayer however no signiﬁcant accu-
mulation is observed and we postulate that unlike against the PC:PG bi-
layer where electrostatic attraction and a large peptide concentration is
required, relatively few Smp24molecules may engage in curve sensing,
causing such a dramatic bilayer rearrangement.
Whilst electrostatic attraction and lipid defect sensingmay be respon-
sible for initial attraction to the PC:PG and PC:PE membrane surface re-
spectively our data suggests that the precise nature of peptide induced
membrane disruption is dependent on lipid composition. Pores of varying
size are observed in the PC:PG bilayer with liposome leakage data sug-
gesting that complete membrane collapse is not taking place supporting
pore formation over a carpet mechanism [8]. Also, the QCM-D data sup-
ports this with increased peptide accumulation (decrease in frequency),
and increased dissipation, consistent with peptide induced membrane
disruption [33]. The dissipation “swing-back” event could result from
the threshold peptide concentration being overcome and peptide
molecules mixing with the bilayer, resulting in a reduced interaction
with the aqueous phase. This data suggests that Smp24 follows the classi-
cal pattern of AMP pore formation, namely (i) electrostatic attraction, (ii)
accumulation and (iii) insertion after reaching a critical threshold concen-
tration [30,31]. Our data indicates Smp24 induced pores that are toroidal
in nature on the basis of the presence of pores of varying size as peptide
concentration increases, leading to complete destruction of the bilayer,
as opposed to increased pore formation also the observation of a Smp24
induced decrease in line tension within the Lo areas observed during in-
teraction with the phase separated bilayer. This phenomenon has been
noted with different membrane-active peptides as examples, PG-1 inter-
acts with the edges of the bilayer and adopts an extended hair pin shape,
in which the hydrophilic N-terminus interacts with phospholipid head
groupswithin the bottom leaﬂet, and the central hydrophilic region inter-
actswith the top leaﬂet,ﬂanked by twohydrophobic regions sittingwith-
in the phospholipid chains [14]. Similarly alpha-helix 5 of the pro-
apoptotic bax peptide, forms pores themitochondrial cell wall via a toroi-
dal mechanism, as evidenced by a loss of line integrity observed around
once-smooth Lo areas [34,35].
Themechanism against PC:PE bilayers is radically different, with the
formation of stratiﬁcations alongwith phase segregation (Fig. 3A–H). Li-
posomal leakage is also less marked than with PC:PG suggesting a car-
pet model is not the primary mechanism. This viewpoint is supported
by the QCM-D results which suggest no accumulation event occurs
(Fig. 5B). A number of AMPs have previously been shown to disrupt
membranes by peptide-mediated non-lamellar formation, suggested
as a mechanism of protein-membrane interaction [35,36]. Membrane
lipids can self-assemble into different phases, includingmicellar, lamel-
lar, hexagonal and cubic phases with the ability of membranes to form
these structures governed by lipid composition [35,36]. Membranes
composed of lipids with a similar headgroup and acyl chain cross sec-
tional area (i.e. PC and PG) favour the formation of planar lipid bilayers,
whereas membranes containing PE lipids prefer inverted micelles,
inverted hexagonal lipid phases or regions with high negative mem-
brane curvature strain [36,37]. In the absence of peptides, the stored
curvature elastic energy causes the bilayer to expand laterally; this
Fig. 4. The effect of 1 μM Smp24 incubation on phase separated bilayers. 1 μM Smp24 was added immediately after capturing the image at time= 0 s. All times shown are at time of full
image capture (image scan line rate = 1.97 Hz, 512 lines). Inset graph showing area/perimeter ratios as a functions of time for individual domains.
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expansion decreases steric hindrance and is thermodynamically
favourable. However, expansion can only occur up to a certain thresh-
old, as changes in membrane conformation cause increased exposure
of the acyl chains to water. Consequently beyond this threshold it be-
comes thermodynamically favourable for an inverse phase to occur.
Typically with PE, a hexagonal II phase (HII) tubular structure forms,
with the head groups orientated toward the centre of the cylinder,
due to its favoured negative curvature. A similar feature was observed
for some integral membrane proteins, which may release locally stored
curvature elastic stress during protein insertion into the bilayer by
allowing the phospholipid chains to dislocate more and forcing head
groups together, making the peptide–lipid assembly thermodynamical-
ly more stable [36,37]. Lipid lateral stress can be induced by proteins
causing membrane structural changes [37–41] and this has suggested
a link between alterations in lipid structure and the modiﬁcation of
cell signalling [41,42]. The areas of disruption that occur after Smp24ex-
posure, seen in the PC:PE bilayer, have a width of between 200 and
350 nm, depending on AMP concentration. However not all the bilayer
is removed, with elongated stratiﬁcations remaining. Based on the pro-
pensity of PE containing bilayers to form non-lamellar phases, Smp24
may induce this process and the stratiﬁcations may be elongated struc-
tures of non lamellar phase lipids. Several other AMPs (e.g. gramicidin S
[42–44], lactoferrin [44,45] sprotegrin-1, PGLa and nisin) have been
shown to form non-lamellar structures in PE containing membranes
[45–47]. Linear and cyclic arginine- and tryptophan-rich AMPs have
been shown to induce de-mixing of a DPPG:DPPE bilayer into separate
domains [47]. AMPs with a high positive net charge, conformational
ﬂexibility and sufﬁcient hydrohobicity have been shown to facilitate
preferential interaction with anionic lipids and the promotion of lipid
lateral segregation [48] This mechanism has also been associated with
species-speciﬁc antimicrobial activity [40,41,49,50].
The inclusion of cardiolipin into the PC:PG bilayer increased the lytic
activity of Smp24, but it is not a prerequisite for increased antimicrobial
activity. For example, cardiolipin inhibits the pore forming ability of
daptomycin in PG liposomes at concentrations of 10 and 20% [50].
5. Concluding remarks
This study has evaluated the membrane disruptive effects of a scor-
pion venom AMP (Smp24) and has provided direct evidence of the
same peptide having multiple mechanisms of action depending on the
membrane lipid composition. Most AMPs, will to some degree, cause
undesirable membrane disruptive effects because they exploit the fun-
damental biophysical parameters that govern cell membrane-protein
interactions. By understanding the precisemechanismbywhich a single
peptide interactswithmultiplemembranemodels, we are better able to
Fig. 5. QCM-D analysis of consecutive injections of increasing peptide concentrations (0.2–2 μM) against both a PCPG and PCPE bilayer. The red arrow indicates the overall direction of
change. (A): Against the PCPG bilayer the bilayer becomes increasingly ﬂuid throughout the time course of the experiment with an increase in peptide interaction with the bilayer,
(B): Against a PCPE bilayer a slight decrease in ﬂuidity is observed throughout the time course of the experiment with no peptide accumulation observed.
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correlate biophysical andbiological studies. Thiswill improve our ability
to assess the potential of a peptide for having a desirable therapeutic
index and to determine if an AMP may interact in a non-lytic fashion
with a membrane which could, in turn, disrupt membrane-mediated
trafﬁcking and cell signalling events. A better understanding of these
processes will ultimately allow us to engineer AMPs which have mini-
mal undesirable effects and hasten their development into clinical use.
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